Australian regulators are investigating how a suspected cancer-causing agent got into a popular heartburn drug.
Zantac, also known by its generic name ranitidine, was taken off the Australian market earlier this month after international reports about the drug’s contamination.
Read more here: https://www.abc.net.au/news/2019-10-15/zantac-test-finds-75-per-cent-contain-possible-carcinogen/11599984
For more from ABC News, click here: https://ab.co/2kxYCZY
If you’re in Australia, you can watch more ABC News content on iview: https://ab.co/2mge4KH
Subscribe to us on YouTube: http://ab.co/1svxLVE
Go deeper on our ABC News In-depth channel: https://ab.co/2lNeBn2
You can also like us on Facebook: http://facebook.com/abcnews.au
Or follow us on Instagram: http://instagram.com/abcnews_au
Or even on Twitter: http://twitter.com/abcnews